Fil LTD Pfizer Inc Transaction History

Fil LTD

$95.2 Billion
Q1 2024

A detailed history of Fil LTD transactions in Pfizer Inc stock. As of the latest transaction made, Fil LTD holds 9,307,448 shares of PFE stock, worth $260 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

9,307,448

Previous 7,582,518 22.75%

Holding current value

$260 Million

Previous $218 Million 18.31%

% of portfolio

0.27%

Previous 0.24%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$25.89 - $29.73 $44.7 Million - $51.3 Million	1,724,930 Added 22.75%	9,307,448 $258 Million
Q4 2023 Feb 13, 2024	BUY	$26.13 - $33.94 $97.6 Million - $127 Million	3,734,595 Added 97.05%	7,582,518 $218 Million
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $23.4 Million - $27.4 Million	730,146 Added 23.42%	3,847,923 $128 Million
Q2 2023 Aug 11, 2023	BUY	$36.12 - $41.79 $105 Million - $122 Million	2,916,148 Added 1446.29%	3,117,777 $114 Million
Q1 2023 May 11, 2023	BUY	$39.39 - $51.28 $872,173 - $1.14 Million	22,142 Added 12.34%	201,629 $8.23 Million

Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $663,908 - $866,659	15,902 Added 9.72%	179,487 $9.2 Million
Q3 2022 Nov 10, 2022	SELL	$43.76 - $53.42 $955,062 - $1.17 Million	-21,825 Reduced 11.77%	163,585 $7.16 Million
Q2 2022 Aug 12, 2022	SELL	$46.53 - $55.17 $873,554 - $1.04 Million	-18,774 Reduced 9.19%	185,410 $9.72 Million
Q1 2022 May 13, 2022	SELL	$45.75 - $56.69 $2.13 Million - $2.64 Million	-46,503 Reduced 18.55%	204,184 $10.6 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $76.8 Million - $114 Million	-1,857,900 Reduced 88.11%	250,687 $14.8 Million
Q3 2021 Nov 15, 2021	SELL	$39.25 - $50.42 $87.4 Million - $112 Million	-2,226,687 Reduced 51.36%	2,108,587 $90.7 Million
Q2 2021 Aug 13, 2021	SELL	$35.91 - $40.68 $12.4 Million - $14.1 Million	-345,460 Reduced 7.38%	4,335,274 $170 Million
Q1 2021 May 14, 2021	SELL	$33.49 - $37.77 $80.5 Million - $90.8 Million	-2,404,770 Reduced 33.94%	4,680,734 $170 Million
Q4 2020 Feb 08, 2021	SELL	$33.47 - $42.56 $203 Million - $259 Million	-6,077,241 Reduced 46.17%	7,085,504 $261 Million
Q3 2020 Nov 13, 2020	SELL	$31.75 - $37.25 $110 Million - $129 Million	-3,455,666 Reduced 20.79%	13,162,745 $483 Million
Q2 2020 Aug 13, 2020	BUY	$30.12 - $36.54 $49.9 Million - $60.6 Million	1,657,781 Added 11.08%	16,618,411 $543 Million
Q1 2020 May 14, 2020	BUY	$27.03 - $38.62 $215 Million - $307 Million	7,941,061 Added 113.13%	14,960,630 $488 Million
Q4 2019 Feb 07, 2020	BUY	$32.92 - $37.36 $83.4 Million - $94.6 Million	2,532,282 Added 56.43%	7,019,569 $275 Million
Q3 2019 Nov 13, 2019	SELL	$32.49 - $42.13 $153 Million - $198 Million	-4,695,680 Reduced 51.13%	4,487,287 $161 Million
Q2 2019 Aug 13, 2019	BUY	$36.98 - $41.52 $204 Million - $228 Million	5,503,333 Added 149.56%	9,182,967 $398 Million
Q1 2019 May 13, 2019	SELL	$37.5 - $41.2 $148 Million - $162 Million	-3,938,336 Reduced 51.7%	3,679,634 $156 Million
Q4 2018 Feb 13, 2019	SELL	$38.47 - $43.86 $226 Million - $258 Million	-5,878,280 Reduced 43.55%	7,617,970 $333 Million
Q3 2018 Nov 09, 2018	BUY	$34.47 - $41.81 $21.4 Million - $25.9 Million	620,432 Added 4.82%	13,496,250 $595 Million
Q2 2018 Aug 10, 2018	BUY	$32.98 - $35.16 $14 Million - $14.9 Million	423,357 Added 3.4%	12,875,818 $467 Million
Q1 2018 May 14, 2018	SELL	$31.91 - $37.02 $82.3 Million - $95.5 Million	-2,580,676 Reduced 17.17%	12,452,461 $442 Million
Q4 2017 Feb 12, 2018	SELL	$33.26 - $35.29 $16.5 Million - $17.5 Million	-496,041 Reduced 3.19%	15,033,137 $545 Million
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $1.02 Million - $1.12 Million	32,860 Added 0.21%	15,529,178 $554 Million
Q2 2017 Aug 29, 2017	BUY	N/A	15,496,318	15,496,318 $521 Million

Others Institutions Holding PFE

# of Institutions

3,159

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fil LTD with notifications on news.

Account